Clinical Trial Update: Janus Kinase Inhibition in Granuloma Annulare [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a Janus kinase inhibitor for granuloma annulare is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Granuloma Annulare

Snippet

Sponsor: William Damsky | Conditions: Granuloma Annulare | Phase 2 | Status: ACTIVE_NOT_RECRUITING